Related Experiment Video
Updated: Sep 18, 2025

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Severe Myocardial Involvement and Persistent Supraventricular Arrhythmia in a Premature Infant Due to Enterovirus
Carolina Montobbio1, Alessio Conte2, Andrea Calandrino1
1Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Insights
Enterovirus infections in newborns can cause severe myocarditis and arrhythmias. This case highlights the need for multi-modal treatment and long-term cardiac monitoring in affected infants.
Area of Science:
- Neonatal cardiology
- Pediatric infectious diseases
- Viral myocarditis
Background:
- Enterovirus (EV) infections are a significant cause of neonatal morbidity, presenting with diverse symptoms including myocarditis and hepatitis.
- Neonatal arrhythmias, especially in preterm or critically ill infants, can severely impair cardiac function and prognosis.
- EVs target cardiac cells, inducing apoptosis and conduction disturbances, leading to potentially life-threatening arrhythmias.
Observation:
- A case of an extremely low-birth-weight preterm infant (27+6 weeks gestation) with EV-induced myocarditis is presented.
- The infant developed supraventricular tachycardia (SVT), pericardial effusion, and bi-atrial enlargement.
- Persistent junctional rhythm was observed until seven months of age, despite multi-agent antiarrhythmic therapy.
Findings:
- EV-induced myocarditis can lead to complex and persistent neonatal arrhythmias.
- A multi-modal treatment approach, including antiarrhythmic medications and potentially electrophysiological interventions, may be necessary.
- Review of literature reveals various rhythm disturbances associated with EV-induced myocarditis in newborns.
Implications:
- Neonatal EV infections pose a risk for long-term cardiovascular comorbidities, necessitating ongoing monitoring (echocardiography, ECG).
- Early recognition and aggressive management of EV-induced arrhythmias are critical for improving infant outcomes.
- Close collaboration between neonatologists and pediatric cardiologists is essential for optimal patient care and follow-up.
Abstract:
Enterovirus (EV) infections in neonates can be transmitted vertically or horizontally, with symptoms ranging from mild to severe, including myocarditis, meningoencephalitis, and hepatitis. Neonates with EV-induced myocarditis may present severe cardiovascular disease with sudden onset of arrhythmia. Neonatal arrhythmias, particularly in low birth weight or critically ill infants, can impair cardiac function and worsen outcomes. EV targets cardiomyocyte receptors, inducing apoptosis pathways and triggering cardiac conduction disturbances. We present an extremely low-birth-weight preterm infant (GW 27 + 6) who developed EV-induced myocarditis, complicated with a sudden onset of supraventricular tachycardia (SVT), pericardial effusion and bi-atrial enlargement. Despite multi-agent regimen, including propranolol, flecainide, and amiodarone, the infant showed persistent junctional rhythm until seven months of age, later transitioning to atrial rhythm with stable cardiac function. A review of previously published rhythm disturbances due to EV-induced myocarditis is presented. Newborns with EV-induced arrhythmia may require a multi-modal treatment such as a multi-agent medical regimen or, in severe non-responsive cases, an electrophysiological approach. EV infections may cause long-term cardiovascular comorbidities (such as left ventricular dysfunction or mitral valve regurgitation), necessitating continuous monitoring through echocardiography and ECG. Collaboration between neonatologists and pediatric cardiologists is crucial for effective treatment and follow-up.
Related Concept Videos
Myocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Myocarditis I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy

